The tobacco endgame-eradicating a worsening epidemic
Eur Heart J
.
2021 Aug 21;42(32):3044-3048.
doi: 10.1093/eurheartj/ehab245.
Authors
Jeffrey Willett
1
,
Stephan Achenbach
2
3
,
Fausto J Pinto
4
5
,
Athena Poppas
6
7
,
Mitchell S V Elkind
8
9
10
Affiliations
1
American Heart Association, 7272 Greenville Ave, Dallas, TX 75231, USA.
2
European Society of Cardiology, The European Heart House, Les Templiers, 2035 route des colles, CS 80179 Biot, 06903 Sophia Antipolis Cedex, France.
3
Department of Cardiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Ulmenweg 18 91054, Erlangen, Germany.
4
World Heart Federation, Rue de Malatrex 32, 1201 Geneva, Switzerland.
5
AIDFM Hospital de Santa Maria c/o Luísa Buscardini, Av. Prof. Egas Moniz Piso, 01 1649-028 Lisboa, Portugal.
6
American College of Cardiology, 2400 N Street NW, Washington, DC 20037, USA.
7
Brown University, Lifespan Cardiovascular Institute, 2 Dudley St., Ste. 360 Providence, RI 02905-3248, USA.
8
American Heart Association, 7272 Greenville Ave, Dallas, TX 75231, USA.
9
Department of Neurology, Columbia University, 710 W 168th St, New York, NY 10032, USA.
10
Department of Epidemiology, Columbia University, 710 W 168th St, New York, NY 10032, USA.
PMID:
34418055
PMCID:
PMC8380060
DOI:
10.1093/eurheartj/ehab245
No abstract available
MeSH terms
Epidemics*
Humans
Nicotiana
Smoking Prevention
Tobacco Products*